VIM and acute myeloid leukemia: Vimentin (increased for the group >200 colonies) is considered a negative prognostic factor in AML [26], whereas SMG1 (decreased for the group >200 colonies) is a potential tumor suppressor in hypoxic tumors and associated with regulation of AML cell proliferation [27].